Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | INPPL1 | O15357 | 3/20 | 0.53 |
| ▸ | INPP5A | Q14642 | 2/20 | 0.53 |
| ▸ | INPP5B | P32019 | 1/20 | 0.53 |
| ▸ | AKT1 | P31749 | 1/20 | 0.47 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.45 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.45 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.45 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | FAAH | O00519 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.45 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.45 |
| ▸ | HTR2C | P28335 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29157938 | 0.98 | INPPL1 (0.52) | INPPL1INPP5AINPP5BAKT1GABRA1 | |
| SCHEMBL2154498 | 0.98 | INPPL1 (0.52) | INPPL1INPP5AINPP5BAKT1GABRA1 | |
| SCHEMBL29158139 | 0.88 | GABRA1 (0.45) | INPPL1INPP5AINPP5BGABRA1GABRB2 | |
| SCHEMBL17537236 | 0.87 | INPPL1 (0.42) | INPPL1INPP5AINPP5BAKT1GABRA1 | |
| SCHEMBL17537209 | 0.87 | INPPL1 (0.42) | INPPL1INPP5AINPP5BAKT1GABRA1 | |
| SCHEMBL13823815 | 0.86 | GABRA1 (0.43) | INPPL1INPP5AINPP5BGABRA1GABRB2 | |
| SCHEMBL11243890 | 0.83 | GABRA1 (0.43) | GABRA1GABRB2GABRG2GABRB3LMNA | |
| SCHEMBL29091292 | 0.82 | GABRA1 (0.39) | GABRA1GABRB2GABRG2GABRB3LMNA | |
| SCHEMBL13152411 | 0.82 | GABRA1 (0.41) | GABRA1GABRB2GABRG2GABRB3LMNA | |
| SCHEMBL19209748 | 0.80 | GABRA1 (0.39) | GABRA1GABRB2GABRG2GABRB3LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101780096-A | Propofol phosphate for injection and preparation method and application thereof | SHAANXI SYNTHETIC PHARMACEUTIC | 2010-07-21 | — | — | CN | claimed |
| CN-117229432-B | Organic rare earth phosphate catalyst and preparation method and application thereof | 传化智联股份有限公司 | 2024-02-13 | — | — | CN | disclosed |
| CN-117229432-A | Organic rare earth phosphate catalyst and preparation method and application thereof | 传化智联股份有限公司 | 2023-12-15 | — | — | CN | disclosed |
| US-11344499-B2 | Nanoparticles as delivery vehicles of active ingredients and methods for the production thereof | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 2022-05-31 | — | — | US | disclosed |
| EP-3638214-B1 | NANOPARTICLES AS DELIVERY VEHICLES OF ACTIVE INGREDIENTS AND METHODS FOR THE PRODUCTION THEREOF | CONSIGLIO NAZIONALE RICERCHE (IT) | 2022-01-26 | — | — | EP | disclosed |
| WO-2021078073-A1 | N-CONTAINING DERIVATIVE OF SUBSTITUTED PHENOL HYDROXY ACID ESTER, AND PREPARATION AND USE THEREOF | 四川大学华西医院 | 2021-04-29 | — | — | WO | disclosed |
| CN-112694414-A | N-containing derivative of substituted phenol hydroxy acid ester, preparation and application | 四川大学华西医院 | 2021-04-23 | — | — | CN | disclosed |
| US-20200206138-A1 | NANOPARTICLES AS DELIVERY VEHICLES OF ACTIVE INGREDIENTS AND METHODS FOR THE PRODUCTION THEREOF | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 2020-07-02 | — | — | US | disclosed |
| EP-3638214-A1 | NANOPARTICLES AS DELIVERY VEHICLES OF ACTIVE INGREDIENTS AND METHODS FOR THE PRODUCTION THEREOF | Consiglio Nazionale Delle Ricerche (IT) | 2020-04-22 | — | — | EP | disclosed |
| US-10561735-B2 | Solid formulations of liquid biologically active agents | PALADIN LABS INC. (CA) | 2020-02-18 | — | — | US | disclosed |
| WO-2004092187-A1 | PHOSPHATE DERIVATIVES | VITAL HEALTH SCIENCES PTY LTD (AU) | 2004-10-28 | — | — | WO | disclosed |
| EP-1318798-A4 | WATER-SOLUBLE PRODRUGS OF PROPOFOL FOR TREATMENT OF MIGRAINE | VYREX CORP (US) | 2004-01-28 | — | — | EP | disclosed |
| EP-1075489-B1 | WATER-SOLUBLE PRODRUGS OF 2,6-DIISOPROPYLPHENOL ANALOGUES | VYREX CORP (US) | 2003-08-20 | — | — | EP | disclosed |
| EP-1318798-A1 | WATER-SOLUBLE PRODRUGS OF PROPOFOL FOR TREATMENT OF MIGRAINE | VYREX CORPORATION (US) | 2003-06-18 | — | — | EP | disclosed |
| US-6362234-B1 | HEADACHES | VYREX CORPORATION | 2002-03-26 | — | — | US | disclosed |
| WO-2002013810-A1 | WATER-SOLUBLE PRODRUGS OF PROPOFOL FOR TREATMENT OF MIGRAINE | VYREX CORPORATION (US) | 2002-02-21 | — | — | WO | disclosed |
| US-6254853-B1 | DRUGS WITH CARRIERS | VYREX CORPORATION | 2001-07-03 | — | — | US | disclosed |
| EP-1075489-A2 | WATER-SOLUBLE PRO-DRUGS OF 2,6-DIISOPROPYLPHENOL ANALOGUES | VYREX CORPORATION (US) | 2001-02-14 | — | — | EP | disclosed |
| WO-1999058555-A2 | WATER-SOLUBLE PRO-DRUGS OF 2,6-DIISOPROPYLPHENOL ANALOGUES | VYREX CORPORATION (US) | 1999-11-18 | — | — | WO | disclosed |
| US-4351780-A | Process for preparing isopropylphenyl/phenyl phosphate | STAUFFER CHEMICAL COMPANY (US) | 1982-09-28 | — | — | US | disclosed |